Dinaciclib is a novel cyclin-dependent kinase inhibitor with significant clinical activity in relapsed and refractory chronic lymphocytic leukemia (Q36000944)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Dinaciclib is a novel cyclin-dependent kinase inhibitor with significant clinical activity in relapsed and refractory chronic lymphocytic leukemia |
scientific article |
Statements
1 reference
Dinaciclib is a novel cyclin-dependent kinase inhibitor with significant clinical activity in relapsed and refractory chronic lymphocytic leukemia (English)
1 reference
J Flynn
1 reference
J Jones
1 reference
A J Johnson
1 reference
L Andritsos
1 reference
K Maddocks
1 reference
S Jaglowski
1 reference
J Hessler
1 reference
M R Grever
1 reference
E Im
1 reference
H Zhou
1 reference
Y Zhu
1 reference
D Zhang
1 reference
K Small
1 reference
R Bannerji
1 reference
J C Byrd
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference